Microbiome Products (LBP & NGP) Development and Manufacturing

Time: 9:00 am
day: Conference Day One

Details:

  • Biose industrie is a pharmaceutical CDMO with development and industrial manufacturing & analytical capabilities
  • In 2024 we manufactured 149 genus of strains in our bioreactors and encapsulation / Tableting / liquid filing capabilities
  • We are specialized from phase I to phase III and commercial manufacturing with new NGP and commensal strictly anaerobic strains
  • We run from R&D batch to Regulatory filing for worldwide applications

Speakers: